MARINUS PHARMACEUTICALS, INC. Long-Term Debt, Maturity, Year Four
MARINUS PHARMACEUTICALS, INC. had Long-Term Debt, Maturity, Year Four of $48.75 million as of 2022-12-31, per its 10-K filed 2023-03-09.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour · last filed 2023-03-09
- 2022-12-31: Long-Term Debt, Maturity, Year Four $48.75M.
| Period end | Long-Term Debt, Maturity, Year Four |
|---|---|
| 2022-12-31 | $48.75M 10-K · filed 2023-03-09 |